272 Millennium - A Marquis Who’s Who Magazine HEALTH AND WELLNESS and a PhD from Showa University and completed residencies in internal medicine at Nikko Memorial Hospital and Hakodate Red Cross Hospital. Further, he completed a fellowship in oncology at Sapporo Medical University. Licensed through the Japanese Society of Internal Medicine, Dr. Akiyama is well regarded for hisdiscoveryof ren-shen-yang-rong-tang, aChinese herbal drug that stimulates hematopoises, and Cu/ Zn-SOD, which is a human antioxidant enzyme that serves as a stress marker for hemodialysis patients. He also discovered cyclicpolylactate, a G-CSF that enhances the efficacy of dendritic cell therapy of cancer. Furthermore, he discovered electrical field therapy, which facilitates the treatment effect of chemotherapy. Dr. Akiyama has been a reviewer for Oncogene and Kidney International, sits on the editorial board of the American Association for Cancer Research, and was elected a fellow of the American College of Physicians. Drawing upon over 35 years of excellence, Dr. Shinichiro Akiyama has been a professor at McGill University in Montreal, Canada, since 2014. Additionally, since 2011, he has served as chief of the board of governors for the integrative oncology section of the International Society of Personalized Medicine and, since 2010, the secretary of the International Society of Integrative Medicine and a professor with the Second Hospital of LanZhou University in China. He became chief executive officer of Natural Medica Japan Co. Ltd. in 2018, performing consulting for patients with intractable diseases, including various solid cancers and organ failure of the heart, kidney, vision, ear and lungs; introducing scientists to companies for FDA approval; and investigating vector development by AI-based platforms. Earlier, Dr. Akiyama thrived as the director of the UDX Hirahata Clinic and the Immune Cell Therapy Center inTokyo, the executive vicepresident ofMitsukaido Sakura Hospital, and a physician-in-chief of the department of internal medicine at Saiyu Soka Hospital. He commenced his career in 1996 as a medical chief of aerospace medicine for the National Space Development Agency of Japan. He holds an MD from Sapporo Medical University DR. SHINICHIRO AKIYAMA ONCOLOGIST, HEMATOLOGIST, RESEARCHER McGill University Kashiwa-shi, Chiba, Japan
RkJQdWJsaXNoZXIy MTQ5NDA2